Continuum Advisory LLC Purchases 14,330 Shares of SPDR S&P Biotech ETF $XBI

Continuum Advisory LLC lifted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 389.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 18,013 shares of the exchange traded fund’s stock after buying an additional 14,330 shares during the period. Continuum Advisory LLC’s holdings in SPDR S&P Biotech ETF were worth $2,851,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the company. InTrack Investment Management Inc grew its holdings in shares of SPDR S&P Biotech ETF by 12.6% during the second quarter. InTrack Investment Management Inc now owns 3,349 shares of the exchange traded fund’s stock valued at $530,000 after buying an additional 374 shares during the last quarter. Tranquilli Financial Advisor LLC lifted its holdings in SPDR S&P Biotech ETF by 5.4% in the second quarter. Tranquilli Financial Advisor LLC now owns 2,926 shares of the exchange traded fund’s stock valued at $463,000 after acquiring an additional 150 shares during the period. Beacon Financial Advisory LLC purchased a new position in shares of SPDR S&P Biotech ETF in the second quarter worth approximately $267,000. Solstein Capital LLC boosted its stake in shares of SPDR S&P Biotech ETF by 51.3% during the 2nd quarter. Solstein Capital LLC now owns 5,848 shares of the exchange traded fund’s stock worth $925,000 after acquiring an additional 1,983 shares during the last quarter. Finally, Rinkey Investments lifted its position in SPDR S&P Biotech ETF by 9.1% during the second quarter. Rinkey Investments now owns 1,828 shares of the exchange traded fund’s stock valued at $289,000 after purchasing an additional 153 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 1.2%

Shares of NYSEARCA:XBI opened at $165.37 on Thursday. The company has a market cap of $10.80 billion, a PE ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a 12-month low of $92.49 and a 12-month high of $169.89. The stock has a 50 day moving average of $157.76 and a 200 day moving average of $140.05.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.